Caris Life Sciences Inc. Common Stock (CAI)
Stock · NASDAQ · Health Care
$30.56as of 10/16/2026
Price chart
Active signals
CAI Signal Track Record
How signals performed across all stocks →What CAI's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 5 | +21.2% | 60% | September 15, 2026 |
| Bollinger Band Breakout | 3 | -5.2% | 33% | September 17, 2026 |
| Any 20-session window (baseline) | +9.6% | 62% |
Computed by MarketWall from daily closing prices since April 6, 2026. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About CAI
Caris Life Sciences, Inc., an artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally. It develops and commercializes solutions to transform healthcare using molecular information, and artificial intelligence/machine learning algorithms. The company's molecular intelligence product portfolio includes MI Profile Platform, a whole exome sequencing (WES)/ w…
- Sector
- Health Care
- Industry
- Medical Specialities
- Employees
- 1,846
- Website
- www.carislifesciences.com/
Fundamentals
- 1-day range
- $28.07$28.97
- Market cap
- $5.65B
- P/E (trailing)
- 76.07
- P/E (forward)
- 77.80
- EPS (trailing)
- $0.37
- Dividend yield
- —
- Beta
- 0.40
- Avg. volume
- 4.83M
How Caris Life Sciences Inc. Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Mar 3, 2026 · via SEC EDGAR / Finnhub
Forecasts
13 analyst ratings
Caris Life Sciences Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- CAICaris Life Sciences Inc. Common Stock$30.56▼ 3.78%Market cap $5.65BP/E 76.07$14.19$33.66
- RDNTRadNet Inc. Common Stock$68.8▼ 2.29%Market cap $5.36BP/E —$50.82$85.84
- CELCCelcuity Inc. Common Stock$56.58▼ 6.17%Market cap $4.55BP/E —$46.51$151.02
- BLLNBillionToOne Inc. Class A Common Stock$98.12▼ 4.49%Market cap $4.22BP/E 128.54$61.96$150.44
- CONConcentra Group Holdings Parent Inc. Common Stock$38.54▼ 1.56%Market cap $3.91BP/E 24.09$18.55$38.07
- VCYTVeracyte Inc. Common Stock$43.12▼ 2.86%Market cap $3.71BP/E 31.17$29.46$60.91
- OSCROscar Health Inc. Class A Common Stock$31.89▼ 4.72%Market cap $8.00BP/E 18.32$10.69$35.01
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| CAI Caris Life Sciences Inc. Common Stock | $5.65B | 76.07 | $30.56 | ▼ 3.78% | $14.19$33.66 |
| RDNT RadNet Inc. Common Stock | $5.36B | — | $68.8 | ▼ 2.29% | $50.82$85.84 |
| CELC Celcuity Inc. Common Stock | $4.55B | — | $56.58 | ▼ 6.17% | $46.51$151.02 |
| BLLN BillionToOne Inc. Class A Common Stock | $4.22B | 128.54 | $98.12 | ▼ 4.49% | $61.96$150.44 |
| CON Concentra Group Holdings Parent Inc. Common Stock | $3.91B | 24.09 | $38.54 | ▼ 1.56% | $18.55$38.07 |
| VCYT Veracyte Inc. Common Stock | $3.71B | 31.17 | $43.12 | ▼ 2.86% | $29.46$60.91 |
| OSCR Oscar Health Inc. Class A Common Stock | $8.00B | 18.32 | $31.89 | ▼ 4.72% | $10.69$35.01 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- IPO Stock Of The Week: Caris Pulls Back After More Than Doubling In Just Two MonthsYahoo · 10/2/2026
- Caris Life Sciences Unveils the Next Evolution of Liquid Biopsy with Enhanced Caris AssureYahoo · 9/29/2026
- Beam Therapeutics: Ignore The Anthropic Noise And Focus On Clinical ProgressSeekingAlpha · 9/29/2026
- Caris Life Sciences Coasts Past A Buy Point; Why This Texas Biotech Researcher Deserves A LookYahoo · 9/22/2026
- Caris Life Sciences: Adjusting My Position After A Recent Steep Incline (Downgrade)SeekingAlpha · 9/22/2026
- Are Medical Stocks Lagging Bristol Myers Squibb (BMY) This Year?Yahoo · 9/18/2026
- Caris Life Sciences Stock Jumped 10% Yesterday. Here’s Where Shares Could Go Further in 2026.Yahoo · 9/18/2026
- Caris Life Sciences: Diagnostics Growth With Room To RunSeekingAlpha · 9/17/2026
Insider Activity
Insider Actions →- John Russel Denton · September 22, 2026 · Sale7.5K @ $31.82
- Brian J. Brille · September 17, 2026 · Option Exercise400.0K @ $2.44
- Brian J. Brille · September 17, 2026 · Sale400.0K @ $30.33
- David Baxley Spetzler · September 4, 2026 · Option Exercise250.0K @ $2.44
- David Baxley Spetzler · September 4, 2026 · Sale119.2K @ $24.76
- David Baxley Spetzler · September 3, 2026 · Option Exercise1.00M @ $2.44
- David Baxley Spetzler · September 3, 2026 · Sale84.9K @ $25.32
- David Baxley Spetzler · September 3, 2026 · Sale393.1K @ $24.76
- Joseph E. Gilliam · August 14, 2026 · Grant13.2K
- T. Danny Phillips · August 14, 2026 · Grant13.2K
- David Paul Fredrickson · August 14, 2026 · Grant13.2K
- Lloyd Minor · August 14, 2026 · Grant13.2K
- Jeff L. Vacirca · August 14, 2026 · Grant13.2K
- Peter M. Castleman · August 14, 2026 · Grant13.2K
- Laura I. Johansen · August 14, 2026 · Grant13.2K
Institutional Ownership
March 31, 2026
- Total shares held
- 150.01M
- Total value held
- $2.47B
- Institutional holders
- 197
- Unknown30.79M
- Unknown18.26M
- Unknown14.39M
- Unknown9.82M
- Unknown8.01M
- Unknown7.36M
- Unknown5.59M
- Unknown4.86M
- Unknown4.37M
- Unknown3.59M
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 10, 2026
CAI Trades Amid Market Rally Following Google's Nuclear Deal
The S&P 500 and Nasdaq reached record highs, with power stocks rallying after news of Google's nuclear deal. The broader market rally could lift many stocks, including CAI, which trades near its 52‑week low. CAI remains in a neutral technical zone with an RSI near 50 and support at $15.28.
CAI Trades Amid Market Rally Following Google's Nuclear Deal. The S&P 500 and Nasdaq reached record highs, with power stocks rallying after news of Google's nuclear deal. The broader market rally could lift many stocks, including CAI, which trades near its 52‑week low. CAI remains in a neutral technical zone with an RSI near 50 and support at $15.28.